Literature DB >> 3041048

Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice.

J G Spivack, D R O'Boyle, N W Fraser.   

Abstract

Herpes simplex virus type 1 was reactivated from the trigeminal ganglia of latently infected mice in a quantitative and time-dependent manner. Novobiocin and coumermycin A1 reversibly inhibited the reactivation of herpes simplex virus type 1. They did not inhibit viral replication in permissive cells (CV-1) but did inhibit replication in cells of neuronal origin (C1300) and acutely infected trigeminal ganglia.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3041048      PMCID： PMC255910          DOI： 10.1128/JVI.61.10.3288-3291.1987

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  26 in total

1.  DNA synthesis inhibitors suppress expression of Epstein-Barr virus in chemically activated human lymphoblastoid cells.

Authors:  M Kawanishi; K Sugawara; Y Ito
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

2.  Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice.

Authors:  R J Klein
Journal:  J Gen Virol       Date:  1980-08       Impact factor: 3.891

Review 3.  Latency and acquired resistance--problems in chemotherapy of herpes infections.

Authors:  G Darby; H J Field
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

4.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  Association of type I DNA topoisomerase with herpes simplex virus.

Authors:  M T Muller; C S Bolles; D S Parris
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

7.  Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase.

Authors:  P D Foglesong; W R Bauer
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Detection of HSV-1 genome in central nervous system of latently infected mice.

Authors:  D L Rock; N W Fraser
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

9.  DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA.

Authors:  N Osheroff; E R Shelton; D L Brutlag
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

10.  Novobiocin; an inhibitor of the repair of UV-induced but not X-ray-induced damage in mammalian cells.

Authors:  A Collins; R Johnson
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971
View more
  11 in total

1.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Detection of herpes simplex virus type 1 transcripts during latent infection in mice.

Authors:  J G Spivack; N W Fraser
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production.

Authors:  Jean M Pesola; Jia Zhu; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing.

Authors:  Xianzhi Jiang; Aziz Alami Chentoufi; Chinhui Hsiang; Dale Carpenter; Nelson Osorio; Lbachir BenMohamed; Nigel W Fraser; Clinton Jones; Steven L Wechsler
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

5.  Human cytomegalovirus induces expression of cellular topoisomerase II.

Authors:  J D Benson; E S Huang
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.

Authors:  J D Benson; E S Huang
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons.

Authors:  M Kosz-Vnenchak; J Jacobson; D M Coen; D M Knipe
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.

Authors:  M D Trousdale; I Steiner; J G Spivack; S L Deshmane; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT.

Authors:  J G Spivack; G M Woods; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.

Authors:  J G Spivack; N W Fraser
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.